TRAFFIC ADVISORY:

President Trump is scheduled to be in Philadelphia on Tuesday, September 15, 2020 at The National Constitution Center (NCC) in the Independence Mall area. Increased police presence is anticipated in Center City throughout Tuesday afternoon and evening. Please allow extra time if you are going to Wills Eye. Please be advised of area street closures to vehicles beginning at 1:00PM on Tuesday 9/15. Pedestrian access will also be limited in the area. This is subject to change and area restrictions, which could widen, will be lifted once the President departs the NCC. There are also demonstrations planned for Tuesday 9/15 around Independence Mall as well as City Avenue.

Leadership

Joseph P. Bilson
Chief Executive Officer

As Chief Executive Officer since 2007, Joseph P. Bilson has developed an impressive record of success.  Mr. Bilson’s leadership has achieved clinical volume goals through aggressive program development and robust financial performance during some of the harshest global economic periods on record.

Mr. Bilson’s accomplishments have been many during his 30 years with Wills Eye.  He strategically planned and developed a very successful network of multi-state ambulatory surgery centers.  He implemented major projects, including Wills On Wheels, a new mobile eye clinic for community outreach and education.  He constructed a state-of-the-art Diagnostic Testing Center with advanced testing equipment not available elsewhere in the Eastern United States.  He also launched the Wills Eye Knowledge Portal for online ophthalmic medical education.

Mr. Bilson also has served as President of the Wills Eye Surgical Network since 1995.  Prior to Wills Eye, he held various senior positions with the Hospital of the University of Pennsylvania and Mercy Catholic Medical Center.  Mr. Bilson attended Penn State University and Rowan University.  He is a graduate of the School of Business with a concentration in Accounting and Finance.  He graduated magna cum laude with honors.  He is president of the American Association of Eye and Ear Centers of Excellence, where he also served as Secretary/Treasurer in 2009.

Under his leadership, Wills Eye has ranked consistently as one of the nation's top ophthalmic specialty hospitals by U.S. News & World Report.

Julia A. Haller, MD
Ophthalmologist-in-Chief

Julia A. Haller, MD, Ophthalmologist-in-Chief at Wills Eye Hospital, is a trailblazing retina surgeon-scientist and leader who has innovated translational advances against blindness on many fronts. Born in Baltimore, she was educated at the Bryn Mawr School, Princeton University and Harvard Medical School. After her internship in surgery, residency in ophthalmology, and retina fellowship at the Wilmer Eye Institute at Johns Hopkins, she served as Wilmer’s first female Chief Resident.

Dr. Haller joined the Hopkins faculty thereafter, and directed the retina fellowship program. She was named the inaugural Katharine Graham Professor of Ophthalmology, and subsequently the inaugural Robert Bond Welch, M.D. Professor. In 2007 she moved to Philadelphia to become Ophthalmologist-in-Chief and William Tasman, MD Endowed Chair at Wills Eye Hospital, and Professor and Chair of Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University and Hospitals. She is a Consultant at the Children’s Hospital of Philadelphia. One of the world’s most renowned retina surgeons, Dr. Haller has published over 400 scientific articles and book chapters, with research interests in retinal pharmacology, macular surgery, venous occlusive disease, diabetic retinopathy, age-related macular degeneration, complicated retinal detachments, health care disparities, and gender equality.

Elected to the National Academy of Medicine in 2019, Dr. Haller’s honors include the Rolex Achievement Award (to a past NCAA lacrosse player), the American Academy of Ophthalmology (AAO) Honor Award, the AAO Senior Achievement Award, the Vitreous Society Senior Honor Award, the Crystal Apple Award (for mentorship) of the American Society of Retina Specialists (ASRS), the Kreissig Award from EURETINA, the President’s Award from Women in Ophthalmology (WIO), a Secretariat Award from the AAO, the Gertrude Pyron Award from the Retina Research Foundation/ASRS, a Lifetime Achievement Award from the AAO, the Louis Braille Award from Associated Services for the Blind, the Heed Award from the Society of Heed Fellows, the Gass Medal from the Macula Society, the Strittmatter Award from the Philadelphia Medical Society (their highest honor), the AAO EnergEYES Award, the WIO Suzanne Véronneau-Troutman Award, Charles L. Schepens, MD, Award from the Retina Research Foundation/AAO and election to the Johns Hopkins Society of Scholars. She holds Chair XVI of the Academia Ophthalmologica Internationalis. She is president of the Women in Medicine Legacy Foundation, Chair of the Society of Heed Fellows, a member of the American Ophthalmological Society Council, and the American Academy of Ophthalmology Foundation Board of Advisors. She is ;past president of the Retina Society, the American Society of Retina Specialists, and the Board of Trustees of the Association of University Professors of Ophthalmology, as well as a founding member of Women in Retina. Her editorial board service includes RETINA, Retinal Physician, Retina Times, Ocular Surgery News, Retina Today, and Ophthalmology Times.

A Director of Bristol Myers Squibb, a former Director of Celgene Corporation, and past Trustee of both Princeton University and the Bryn Mawr School, Dr. Haller serves on the boards of the Johns Hopkins Medical and Surgical Association, The College of Physicians of Philadelphia (where she is Vice-Chair), and the Philadelphia Orchestra Association. She and her husband, John D. Gottsch, M.D, the Margaret C. Mosher Professor of Ophthalmology at Hopkins, have five children: John, Natalie, Will, Alex, and Clare.